Figure 4.
Figure 4. Mean daily received doses of interferon-alfa and hydroxyurea by randomized dose (data unavailable for MRC CML IV patients). Solid line indicates high-dose IFN-alfa (5 MIU/m2 daily); dotted line, low-dose IFN-alfa (3 MIU 5 times a week). Note: some patients started IFN several weeks after randomization. (A) Doses of interferon-alfa. (B) Doses of hydroxyurea.

Mean daily received doses of interferon-alfa and hydroxyurea by randomized dose (data unavailable for MRC CML IV patients). Solid line indicates high-dose IFN-alfa (5 MIU/m2 daily); dotted line, low-dose IFN-alfa (3 MIU 5 times a week). Note: some patients started IFN several weeks after randomization. (A) Doses of interferon-alfa. (B) Doses of hydroxyurea.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal